George Yancopoulos, President Regeneron Laboratori at REGENERON PHARMACEUTICALS INC (REGN), sold 44,960 shares at $542.72 ($23.8M) on 2015-12-02, disclosed to the SEC on 2015-12-04.
Scheduled sale ($23.8M) by President Regeneron Laboratori under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,612 | $0 | 0.0% |
| 2 | $542.72 | 1,098 | $596K | 2.5% |
| 3 | $543.57 | 602 | $327K | 1.4% |
| 4 | $544.52 | 4,290 | $2.3M | 9.8% |
| 5 | $545.51 | 5,611 | $3.1M | 12.9% |
| 6 | $546.36 | 3,038 |
| $1.7M |
| 7.0% |
| 7 | $547.45 | 914 | $500K | 2.1% |
| 8 | $548.49 | 3,780 | $2.1M | 8.7% |
| 9 | $549.57 | 4,407 | $2.4M | 10.2% |
| 10 | $550.47 | 6,390 | $3.5M | 14.8% |
| 11 | $551.43 | 4,992 | $2.8M | 11.6% |
| 12 | $552.54 | 3,625 | $2.0M | 8.4% |
| 13 | $553.32 | 1,600 | $885K | 3.7% |
| 14 | $554.58 | 1,101 | $611K | 2.6% |
| 15 | $555.26 | 1,900 | $1.1M | 4.4% |
| Total | $529.35 avg | 44,960 | $23.8M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |